Mode
Text Size
Log in / Sign up

Cohort study in Portuguese families finds co-segregation of serious mental illnesses and rare CHD2 variant

Cohort study in Portuguese families finds co-segregation of serious mental illnesses and rare CHD2 v…
Photo by Laura / Unsplash
Key Takeaway
Interpret rare CHD2 variant findings in serious mental illness as preliminary associations from a single founder family.

This observational cohort study investigated the shared genetic architecture of serious mental illnesses (schizophrenia, bipolar disorder, major depression, and autism) using 173 multiplex families from the Portuguese Island Collection, a founder population. The study did not involve a specific intervention or comparator but analyzed familial patterns and conducted genetic sequencing.

The main results showed that co-segregation of psychotic and mood disorders occurred in 28% of the studied families. Co-segregation of intellectual disability or autism spectrum disorder with schizophrenia and mood disorder phenotypes was demonstrated in 7% of families. In a detailed analysis of one three-generation family using whole-genome sequencing, researchers identified an extremely rare predicted loss-of-function mutation in the CHD2 gene.

No safety or tolerability data were reported as this was a genetic association study. Key limitations include the observational design within a specific founder population, which limits generalizability, and the genetic finding being based on analysis of a single family. The study authors appropriately note that the CHD2 mutation 'suggests' disruption 'may lead to' diverse phenotypes, avoiding claims of proven causation. Practice relevance is not reported, and these findings should be viewed as preliminary genetic associations requiring replication in broader populations.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
In an analysis of 173 multiplex families from the Portuguese Island Collection (PIC) we characterize the shared genetic architecture of serious mental illnesses (SMI) including schizophrenia (SZ), bipolar disorder (BP), major depression (MDD), and autism (ASD). Within this cohort, co-segregation of psychotic and mood disorders occurred in 28% of families, while 7% demonstrated co-segregation of intellectual disability or ASD with SZ and mood disorder phenotypes. Whole-genome sequencing (WGS) was performed on a three-generation PIC family to identify rare, large-effect variants. We identified an extremely rare predicted loss of function (LoF) mutation in the Chromodomain Helicase DNA Binding Protein 2 (CHD2) gene. These results demonstrate that high-density multiplex families in founder populations are a powerful resource for mapping rare, large-effect variants that cross clinical diagnostic boundaries, as the identified CHD2 mutation suggests that the disruption of a single neurodevelopmental gene may lead to diverse SMI phenotypes. By combining population and family-based methodologies, this approach leverages shared genetic backgrounds and environments to provide a unique opportunity for cellular studies to explore the biological mechanisms underlying SMI, offering significant potential to inform future functional research and identify novel therapeutic targets.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.